Pharmacological activity of Guarana
(Paullinia cupana Mart.) in laboratory animals
by
Espinola EB, Dias RF, Mattei R, Carlini EA.
Laboratorio de Tecnologia Farmaceutica,
Universidade Federal da Paraiba, Brazil.
J Ethnopharmacol 1997 Feb;55(3):223-9

ABSTRACT

Mice that ingested a suspension of guarana (Paullinia cupana, Sapindaceae) in a dose of 0.3 mg/ml showed a significant increase in physical capacity when subjected to a stressful situation such as forced swimming after 100 and 200 days of treatment. Such an effect, however, was not obtained with a concentration of 3.0 mg/ml, nor with the ingestion of a suspension of ginseng 5.0 mg/ml, nor of a solution of caffeine 0.1 mg/ml. Guarana, both after a single (3.0 and 30 mg/kg) or chronic administrations (0.3 mg/ml), was able to partially reverse the amnesic effect of scopolamine as measured through a passive avoidance test in mice and rats, indicating a positive effect on memory acquisition. However, no effect was observed when an active avoidance task was used in rats, even after 20 days of guarana administration. There was also a tendency of rats treated with 0.3 mg/ml of guarana to better maintain the memory of a Lashley III maze path. The animals had the same average lifespan, indicating a low toxicity of guarana, even after 23 months of treatment.

Caffeine
Guarana
Black tea
Hydergine
Blueberries
Vinpocetine
New brain cells
Centrophenoxine
The memory switch?
Cholinesterase inhibitors
Anti-muscarinics/dumb-drug euphoria

Refs
HOME
HedWeb
Future Opioids
BLTC Research
Utopian Pharmacology
SMART DRUGS 2: review
The Hedonistic Imperative
Critique of Huxley's Brave New World

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family